Despite considerable progress has made in the clinical treatment of atrial fibrillation currently，it still represents one of the major causes of cardiovascular morbidity and mortality worldwide. It has a great prevalence particularly in the elderly population and in patients with basic diseases. And with the aging of our society，the problem of atrial fibrillation has also increased the social and economic burden. Cardiologists and surgeons are gradually understanding the pathogenesis of it and ameliorating the therapeutic methods of it. And through strengthening cooperation，we can improve the cure rate of atrial fibrillation and reduce operation-related complications. In the treatment of non-paroxysmal atrial fibrillation，hybrid ablation which combined with respective advantages of endocardial and epicardial ablation seems to have a better clinical effect. Therefore，we searched relevant literature and summarized the progress of hybrid ablation in the treatment of atrial fibrillation according to the clinical findings.